Silverarc Capital Management’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.5M Buy
124,658
+75,430
+153% +$16.9M 3.36% 12
2025
Q4
$10.5M Sell
49,228
-4,326
-8% -$893K 1.52% 22
2025
Q3
$10.6M Sell
53,554
-32,998
-38% -$6.15M 1.54% 23
2025
Q2
$14.9M Buy
86,552
+10,801
+14% +$1.76M 3.06% 15
2025
Q1
$11.8M Buy
75,751
+24,260
+47% +$3.47M 2.47% 13
2024
Q4
$7.09M Buy
51,491
+46,491
+930% +$6.11M 1.59% 22
2024
Q3
$747K Buy
+5,000
New +$675K 0.17% 61
2023
Q1
Sell
-23,151
Closed -$2.83M 76
2022
Q4
$2.83M Buy
23,151
+18,151
+363% +$2.11M 0.97% 43
2022
Q3
$516K Buy
+5,000
New +$474K 0.22% 68
2022
Q2
Sell
-25,000
Closed -$1.43K 73
2022
Q1
$1.43K Buy
+25,000
New +$2.9M 0.68% 42
2021
Q3
Sell
-5,599
Closed -$737 87
2021
Q2
$737 Sell
5,599
-13,095
-70% -$1.74M 0.36% 71
2021
Q1
$2.41M Buy
18,694
+1,138
+6% +$173K 1.35% 29
2020
Q4
$2.93M Buy
+17,556
New +$2.9M 1.79% 21

Other funds holding ASND